As US tech stocks fall on AI and war fears, are valuations attractive now?
US megacap technology stocks, long the driving force behind a bull run spanning more than three years, are undergoing a sharp valuation reset
Bitcoin
Bitcoin
Nvidia just invested in Marvell stock: should you too?
Marvell Technology Inc (NASDAQ: MRVL) is inching higher after Nvidia announced a [MONEY value="2000000000" currency="usd" notation="long" replace="false"] direct investment and a strategic partnership
Bitcoin
US banks raise costs for private credit funds as valuation fears grow: report
US banks are raising borrowing costs for some loans to private credit funds amid growing concerns over valuations, a shift that could pressure
Bitcoin
Hormuz closure hits global fertiliser, ammonia trade
Global fertiliser and ammonia markets are bracing for intense pressure following the effective closure of the Strait of Hormuz, as diplomatic negotiations between
Bitcoin
Commodity wrap: Gold surge nearly 2%; Brent set for biggest monthly gain
Gold and silver surged on Tuesday as safe-haven demand picked up, benefiting the precious metals. However, gold fell 13% in March, and was
Business
SCHD ETF dividend yield too low? Top 3 alternatives to consider
The Schwab US Dividend Equity ETF (SCHD) has accumulated over $83 billion in assets, making it one of the biggest dividend funds in
Business
Bulgaria to launch first EU support scheme for energy-heavy industry
Bulgaria is poised to become the first European Union member state to introduce a dedicated support scheme for energy-intensive industries, aiming to shield
Business
Nebius stock gains 4.5% on plans to build $10B Finland data centre
AI infrastructure firm Nebius Group is accelerating its push into Europe with plans to develop a 310-megawatt data centre in Finland. The Amsterdam-based
Business
Canada GDP edges up 0.1% in January as services stall
Canada’s economy posted a modest gain in January, with gross domestic product rising 0.1% from December, Statistics Canada said. The increase followed a
Business
Novo cuts Ozempic, Wegovy prices up to 48% as generics surge
Novo Nordisk cut prices for its diabetes and weight-loss injections Ozempic and Wegovy in India on Tuesday, marking a second reduction aimed at